Search Results - "CONTRERAS, Liliana N"

Refine Results
  1. 1

    Salivary testosterone: a reliable approach to the diagnosis of male hypogonadism by Arregger, Alejandro L., Contreras, Liliana N., Tumilasci, Omar R., Aquilano, Daniel R., Cardoso, Estela M. L.

    Published in Clinical endocrinology (Oxford) (01-11-2007)
    “…Summary Objective  This study was to demonstrate that Sal‐T is a reliable biomarker of androgen status in the diagnosis of male hypogonadism. Design  In order…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Adrenocortical function in hypotensive patients with end stage renal disease by Arregger, Alejandro L., Cardoso, Estela M.L., Zucchini, Alfredo, Aguirre, Elvira C., Elbert, Alicia, Contreras, Liliana N.

    Published in Steroids (01-06-2014)
    “…•Salivary cortisol and aldosterone are surrogate markers of circulating steroids.•Adrenal insufficiency was detected in 20% of hypotensive patients on…”
    Get full text
    Journal Article
  4. 4

    An accurate, non-invasive approach to diagnose Cushing’s syndrome in at-risk populations by Cardoso, Estela M.L., Arregger, Alejandro L., Monardes, Gloria, Contreras, Liliana N.

    Published in Steroids (01-05-2013)
    “…► Cushing’s syndrome was detected in 1.5% of at-risk outpatients in Argentina. ► Late-night cortisol levels in saliva and urine are highly sensitive detectors…”
    Get full text
    Journal Article
  5. 5

    Diagnostic value of salivary cortisol in Cushing's syndrome (CS) by Cardoso, Estela M. L., Arregger, Alejandro L., Tumilasci, Omar R., Contreras, Liliana N.

    Published in Clinical endocrinology (Oxford) (01-04-2009)
    “…Summary Objective  The diagnosis of Cushing's syndrome (CS) remains a challenge in clinical endocrinology. The aim of this study was to determine the…”
    Get full text
    Journal Article
  6. 6

    Diagnostic value of salivary cortisol in end stage renal disease by Arregger, Alejandro L., Cardoso, Estela M.L., Tumilasci, Omar, Contreras, Liliana N.

    Published in Steroids (2008)
    “…Salivary cortisol has been proposed a surrogate marker for free serum cortisol measurements. The aim of this study was to ascertain the diagnostic value of…”
    Get full text
    Journal Article
  7. 7

    Hormonal secretion and quality of life in Nelson syndrome and Cushing disease after long acting repeatable octreotide: a short series and update by Arregger, Alejandro L, Cardoso, Estela M L, Sandoval, Olga B, Monardes Tumilasci, Elida G, Sanchez, Rocío, Contreras, Liliana N

    Published in American journal of therapeutics (01-07-2014)
    “…Clinical management of persistent adrenocorticotropin hormone (ACTH) excess in Nelson syndrome (NS) and Cushing disease (CD) remains a challenge. Somatostatin…”
    Get full text
    Journal Article
  8. 8

    Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal disease by CARDOSO, Estela M. L, CONTRERAS, Liliana N, TUMILASCI, Elida G, ELBERT, Alicia, AGUIRRE, Elvira C, AQUILANO, Daniel R, ARREGGER, Alejandro L

    Published in Nephrology, dialysis, transplantation (01-02-2011)
    “…Hypogonadism is frequent in patients with end-stage renal disease (ESRD). Salivary testosterone (Sal-T) is a non-invasive tool to screen androgen deficiency in…”
    Get full text
    Journal Article
  9. 9

    Assessment of salivary urea as a less invasive alternative to serum determinations by Cardoso, Estela M. L., Arregger, Alejandro L., Tumilasci, Omar R., Elbert, Alicia, Contreras, Liliana N.

    “…Objective. Experimental studies describe how urea is excreted through salivary glands and correlates with serum levels independently of salivary flow rate…”
    Get full text
    Journal Article
  10. 10

    A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin by Contreras, Liliana N., Arregger, Alejandro L., Persi, Gabriel G., Gonzalez, Natalia S., Cardoso, Estela M.

    Published in Clinical endocrinology (Oxford) (01-12-2004)
    “…Summary objective  The intravenous low‐dose ACTH test has been proposed as a sensitive tool to assess adrenal function through circulating steroids. The aims…”
    Get full text
    Journal Article
  11. 11

    Assessment of adrenal function by measurement of salivary steroids in response to corticotrophin in patients infected with human immunodeficiency virus by Cardoso, Estela, Persi, Gabriel, González, Natalia, Tumilasci, Omar, Arregger, Alejandro, Burgos, Myriam, Rodríguez, Viviana, Molina, Ana, Contreras, Liliana N.

    Published in Steroids (01-04-2007)
    “…Adrenal insufficiency has been reported among critically ill HIV-infected patients. This is the first study that attempts to detect subclinical hypoadrenal…”
    Get full text
    Journal Article
  12. 12

    Effect of translocator protein (18 kDa)-ligand binding on neurotransmitter-induced salivary secretion in rat submandibular glands by Ostuni, Mariano A., Tumilasci, Omar R., Péranzi, Gabriel, Cardoso, Estela M. L., Contreras, Liliana N., Arregger, Alejandro L., Papadopoulos, Vassilios, Lacapere, Jean-Jacques

    Published in Biology of the cell (01-07-2008)
    “…Background information. TSPO (translocator protein), previously known as PBR (peripheral‐type benzodiazepine receptor), is a ubiquitous 18 kDa transmembrane…”
    Get full text
    Journal Article
  13. 13

    Standardization of a simple method to study whole saliva: clinical use in different pathologies by Tumilasci, Omar R, Cardoso, Estela M L, Contreras, Liliana N, Belforte, Juan, Arregger, Alejandro L, Ostuni, Mariano A

    “…The present study describes a methodology to assess the salivary flow rate in humans. Whole saliva was obtained from the floor of the mouth with a plastic…”
    Get full text
    Journal Article
  14. 14

    MON-165 Utility of Salivary Cortisol After 1 Mg Oral Dexamethasone in the Evaluation of Incidental Adrenal Tumors by Arregger, Alejandro L, Contreras, Liliana N, Cardoso, Estela M L, Céspedes, María E

    Published in Journal of the Endocrine Society (08-05-2020)
    “…The subclinical Cushing′s syndrome (SCS) is found in 20% of incidental adrenal tumors (AI). The overnight 1 mg oral dexamethasone suppression test (DST) with…”
    Get full text
    Journal Article
  15. 15

    Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number by Gertz, B J, Contreras, L N, McComb, D J, Kovacs, K, Tyrrell, J B, Dallman, M F

    Published in Endocrinology (Philadelphia) (01-01-1987)
    “…The effect of chronic administration of CRF on rat pituitary morphology was studied. Experimental animals received CRF (10 micrograms/day) over a period of 52…”
    Get more information
    Journal Article
  16. 16

    Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome by Bruno, O D, Rossi, M A, Contreras, L N, Gómez, R M, Galparsoro, G, Cazado, E, Kral, M, Leber, B, Arias, D

    Published in Acta endocrinologica (Copenhagen) (01-06-1985)
    “…Seventeen patients with well-proven Cushing's syndrome (13 with Cushing's disease, 3 with adrenal tumour and 1 presenting ectopic ACTH syndrome caused by…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Urinary cortisol in the assessment of pituitary-adrenal function: utility of 24-hour and spot determinations by Contreras, L N, Hane, S, Tyrrell, J B

    “…To more conveniently assess dynamic changes in the biologically active fraction of cortisol, we measured cortisol in 1-h urine samples obtained from 0700-0800…”
    Get more information
    Journal Article